Literature DB >> 3791644

The pharmacodynamic properties of lorazepam and methylphenidate drugs on event-related potentials and power spectral analysis in normal subjects.

R Berchou, S Chayasirisobhon, V Green, K Mason.   

Abstract

The effect of lorazepam and methylphenidate on the ERPs and power spectral analysis was studied. Lorazepam caused prolonged latency and decreased amplitude of N200 and P300. This result suggests that lorazepam affects the neural processing of cognitive function. The drowsiness induced by lorazepam correlated inversely with alpha frequency power, but had no direct correlation with fast activity. On the contrary, when methylphenidate was given, there was no change in ERPs. There was an increase in percent alpha frequency correlated with the alertness of the subjects. An analysis of variance involving the factors of drug and time of rating showed that subjects showed a significant (p less than 0.0001) decrease in alertness over time while receiving lorazepam, and a significant (p less than 0.05) increase in alertness over time while receiving methylphenidate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3791644

Source DB:  PubMed          Journal:  Clin Electroencephalogr        ISSN: 0009-9155


  5 in total

1.  Characterization of Glutamatergic and GABAA-Mediated Neurotransmission in Motor and Dorsolateral Prefrontal Cortex Using Paired-Pulse TMS-EEG.

Authors:  Robin F H Cash; Yoshihiro Noda; Reza Zomorrodi; Natasha Radhu; Faranak Farzan; Tarek K Rajji; Paul B Fitzgerald; Robert Chen; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

2.  Comparison of local spectral modulation, and temporal correlation, of simultaneously recorded EEG/fMRI signals during ketamine and midazolam sedation.

Authors:  Anna Forsyth; Rebecca McMillan; Doug Campbell; Gemma Malpas; Elizabeth Maxwell; Jamie Sleigh; Juergen Dukart; Joerg F Hipp; Suresh D Muthukumaraswamy
Journal:  Psychopharmacology (Berl)       Date:  2018-11-14       Impact factor: 4.530

3.  Effects of a small dose of triazolam on P300 and resting EEG.

Authors:  J Urata; M Uchiyama; M Iyo; T Enomoto; T Hayakawa; M Tomiyama; T Nakajima; H Sasaki; S Shirakawa; K Wada; S Fukui; H Yamadera; M Okawa
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

4.  Effects of etizolam and ethyl loflazepate on the P300 event-related potential in healthy subjects.

Authors:  Goro Fukami; Tasuku Hashimoto; Yukihiko Shirayama; Tadashi Hasegawa; Hiroyuki Watanabe; Mihisa Fujisaki; Kenji Hashimoto; Masaomi Iyo
Journal:  Ann Gen Psychiatry       Date:  2010-11-03       Impact factor: 3.455

5.  The KCNH3 inhibitor ASP2905 shows potential in the treatment of attention deficit/hyperactivity disorder.

Authors:  Shinji Takahashi; Makoto Ohmiya; Sokichi Honda; Keni Ni
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.